SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-040369
Filing Date
2021-06-14
Accepted
2021-06-14 19:00:57
Documents
1
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1546
  Complete submission text file 0001209191-21-040369.txt   3001
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Issuer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEUROCRINE BIOSCIENCES, INC. 12780 EL CAMINO REAL SAN DIEO CA 92130
Business Address
ROBERTS EIRY (Reporting) CIK: 0001727606 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33497 | Film No.: 211016153